Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 1/2016

01-02-2016 | Letter to the Editor

Glycemic control and the risk of microvascular complications in people with diabetes mellitus

Authors: Ilker Tasci, Bilgin Bahadir Basgoz, Kenan Saglam

Published in: Acta Diabetologica | Issue 1/2016

Login to get access

Excerpt

Dear Editor-in-Chief, …
Literature
1.
Anjana RM, Shanthirani CS, Unnikrishnan R, Mugilan P, Amutha A, Nair HD, Subhashini S, Venkatesan U, Ali MK, Ranjani H, Mohan V (2015) Regularity of follow-up, glycemic burden, and risk of microvascular complications in patients with type 2 diabetes: a 9-year follow-up study. Acta Diabetol. 52:601–609 doi:10.​1007/​s00592-014-0701-0 CrossRefPubMed
2.
Mohan V, Deepa R, Rani SS, Premalatha G (2001) Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: the Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 38:682–687CrossRefPubMed
3.
Premalatha G, Shanthirani S, Deepa R, Markovitz J, Mohan V (2000) Prevalence and risk factors of peripheral vascular disease in a selected South Indian population: the Chennai Urban Population Study. Diabetes Care 23:1295–1300CrossRefPubMed
4.
Tasci I et al (2013) Comment on: Hanssen et al. Associations between the ankle-brachial index and cardiovascular and all-cause mortality are similar in individuals without and with type 2 diabetes: nineteen-year follow-up of a population-based cohort study. Diabetes Care 2012;35:1731-1735. Diabetes Care 36:e25–e26PubMedCentralCrossRefPubMed
5.
Bozkurt AK, Tasci I, Tabak O, Gumus M, Kaplan Y (2011) Peripheral artery disease assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherothrombosis–CAREFUL study: a national, multi-center, cross-sectional observational study. BMC Cardiovasc Disord 19(11):4CrossRef
Metadata
Title
Glycemic control and the risk of microvascular complications in people with diabetes mellitus
Authors
Ilker Tasci
Bilgin Bahadir Basgoz
Kenan Saglam
Publication date
01-02-2016
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 1/2016
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-015-0778-0

Other articles of this Issue 1/2016

Acta Diabetologica 1/2016 Go to the issue

Letter to the Editor

Chronic inflammation in offspring of patients with type 2 diabetes and albuminuria

Original Article

Prediction of type 1 diabetes in Sardinian schoolchildren using islet cell autoantibodies: 10-year follow-up of the Sardinian schoolchildren type 1 diabetes prediction study

Letter to the Editor

Re: Follow-up of women with previous gestational diabetes

Original Article

Identification of predictors of response to basal insulin and DPP4 inhibitors in patients with type 2 diabetes failing to other therapies

Short Communication

Maternal hair metabolome analysis identifies a potential marker of lipid peroxidation in gestational diabetes mellitus

Original Article

Reducing the risk of metabolic syndrome at the worksite: preliminary experience with an ecological approach
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits